Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dongke Pharmaceutical, officially Xining Dongke Pharmaceutical Co., Ltd., is a Chinese pharmaceutical enterprise specializing in the development, manufacturing, and marketing of Traditional Chinese Medicine (TCM) and modern therapeutic preparations. Based in the Qinghai province, the company is widely recognized for its expertise in external patches and plasters, particularly the 'Dongke Plaster' series used for musculoskeletal pain and rheumatism. Its product portfolio also encompasses oral solid dosage forms such as capsules and granules targeting respiratory, gynecological, and cardiovascular conditions. Dongke Pharmaceutical operates large-scale manufacturing facilities that adhere to national Good Manufacturing Practice (GMP) standards, integrating regional herbal resources with modern pharmaceutical technology. The company maintains a strong presence in the domestic Chinese market while exploring international distribution for its natural product-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dongke Pharmaceutical.